Abstract
The introduction of tyrosine kinase inhibitors (TKIs) against vascular endothelial growth factor receptors (VEGFRs) has transformed the therapeutic la......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
